Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Colleen Marie Feltmate, M.D.

Concepts (277)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms16202313572.130 Why?
Cystadenocarcinoma, Serous520224791.270 Why?
Vulvar Neoplasms420182631.240 Why?
Ovarian Neoplasms23202248781.220 Why?
Hysterectomy1020239041.150 Why?
Hydatidiform Mole1020082540.780 Why?
Chorionic Gonadotropin1020074570.770 Why?
Leukocytosis220132510.750 Why?
Placenta Accreta120232370.670 Why?
Carcinoma4202223310.620 Why?
Paget Disease, Extramammary12018510.590 Why?
Gynecology120235280.570 Why?
Sentinel Lymph Node Biopsy320207330.570 Why?
Uterine Cervical Neoplasms6202220030.560 Why?
Genital Neoplasms, Female320235330.550 Why?
Obstetrics120236670.530 Why?
Uterine Neoplasms9201014390.500 Why?
Neoplasm Recurrence, Local13202092760.500 Why?
Carcinosarcoma120151040.470 Why?
Adenocarcinoma, Clear Cell120152170.440 Why?
Laparoscopy6202221470.430 Why?
MutS Homolog 2 Protein120121950.400 Why?
Papillomaviridae1201811170.400 Why?
Trophoblastic Tumor, Placental Site22002200.400 Why?
Papillomavirus Infections3202116070.390 Why?
Fallopian Tube Neoplasms520183280.380 Why?
Carcinoma in Situ320187960.380 Why?
Genes, BRCA2220136030.370 Why?
Adenocarcinoma5201763150.370 Why?
Genes, BRCA1220137650.350 Why?
Cell Transformation, Neoplastic2201828280.330 Why?
Neoplasms, Multiple Primary120125860.320 Why?
Carcinoma, Endometrioid320202760.320 Why?
Neoplasm Staging162022111520.310 Why?
Endometriosis220148740.300 Why?
Carcinoma, Squamous Cell3201840240.300 Why?
Neoplasms, Cystic, Mucinous, and Serous220201940.280 Why?
Loss of Heterozygosity220056590.270 Why?
Adenocarcinoma, Mucinous320145170.260 Why?
Ovariectomy420136110.260 Why?
Germ-Line Mutation1201318410.250 Why?
Microdissection120051510.240 Why?
Female7020233912700.240 Why?
Heterozygote2201227980.220 Why?
Appendiceal Neoplasms120051550.220 Why?
Lymphatic Metastasis4202029430.220 Why?
Internship and Residency1202358700.210 Why?
BRCA2 Protein220237980.210 Why?
Chemotherapy, Adjuvant6202135290.200 Why?
Immunohistochemistry52020110710.200 Why?
Retrospective Studies242022803720.200 Why?
Patient Discharge1201534760.200 Why?
Brachytherapy3202012380.200 Why?
Robotics320158740.200 Why?
BRCA1 Protein2202311470.180 Why?
Lasers120059520.180 Why?
Preoperative Period220135550.170 Why?
Gynecologic Surgical Procedures320233040.170 Why?
Aged2920211691520.170 Why?
Treatment Refusal120034300.170 Why?
Middle Aged3420212203520.170 Why?
Humans7120237606210.160 Why?
Pregnancy182023297490.160 Why?
Uterus120226510.160 Why?
Lymph Node Excision3202013030.160 Why?
Prognosis102020296580.160 Why?
Neoplasms, Glandular and Epithelial220134870.150 Why?
Alphapapillomavirus120212180.150 Why?
Aged, 80 and over152021589950.150 Why?
Fallopian Tubes120181780.150 Why?
Education, Medical, Continuing120238300.150 Why?
Cyclin-Dependent Kinase Inhibitor p16120216980.150 Why?
Genome1200517390.140 Why?
Adult3320212199940.140 Why?
Cervix Uteri120215820.140 Why?
Alleles2200568980.140 Why?
Neoplasm Invasiveness4202036180.130 Why?
Antimetabolites, Antineoplastic220106400.130 Why?
Ovarian Cysts120161080.120 Why?
Genome, Human2200544170.120 Why?
Early Detection of Cancer2202132020.120 Why?
Neoplastic Syndromes, Hereditary120172430.120 Why?
Placenta1202317020.110 Why?
Radiotherapy, Adjuvant2202017910.110 Why?
Neoadjuvant Therapy5202128210.110 Why?
Ovarian Diseases120141370.110 Why?
Antineoplastic Combined Chemotherapy Protocols42018117120.110 Why?
Precancerous Conditions220189770.110 Why?
Disease-Free Survival6202268280.110 Why?
CA-125 Antigen220132790.110 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120173800.100 Why?
Methotrexate2201017190.100 Why?
Organoids120187290.100 Why?
Risk Factors112023743590.100 Why?
New England2200610500.100 Why?
Perioperative Care2202010370.100 Why?
Ovary120169580.090 Why?
Cadherins120168980.090 Why?
Genotype12005129600.090 Why?
High-Throughput Nucleotide Sequencing2202036160.090 Why?
Cohort Studies82023413350.090 Why?
Cell Lineage1201825330.080 Why?
Postoperative Complications42023156970.080 Why?
DNA Repair1201820390.080 Why?
Clinical Protocols1201514400.080 Why?
Gene Expression Regulation, Neoplastic2202085150.080 Why?
Granulosa Cell Tumor12009720.080 Why?
Peritoneal Neoplasms220137070.080 Why?
Cell Proliferation32020104460.080 Why?
Death120136780.080 Why?
Venous Thromboembolism1202118640.080 Why?
Human papillomavirus 16120102650.070 Why?
Pregnancy Complications, Neoplastic120102550.070 Why?
Survival Rate32020128080.070 Why?
Surgery, Computer-Assisted1201510080.070 Why?
Gravidity12006500.070 Why?
Insurance Coverage1201819390.070 Why?
Epithelial Cells1201836630.070 Why?
Incidence42021213920.070 Why?
Insurance, Health1201825010.060 Why?
Lymph Nodes1201734860.060 Why?
Dilatation and Curettage12004520.060 Why?
Pelvic Neoplasms120072480.060 Why?
Remission Induction2201023920.060 Why?
Blood Vessels1201011120.060 Why?
Exercise1202157870.060 Why?
Feasibility Studies3202152010.060 Why?
Tumor Suppressor Protein p534202029190.060 Why?
Anesthesia1201515840.060 Why?
Cell Movement1201652060.060 Why?
Ki-67 Antigen120066310.060 Why?
Maternal Age120068070.060 Why?
Angiogenesis Inhibitors1201320490.060 Why?
Prospective Studies62021543030.050 Why?
Telemedicine1202130180.050 Why?
Radiotherapy Dosage3201528970.050 Why?
Tumor Cells, Cultured3202061310.050 Why?
Evidence-Based Medicine1201536960.050 Why?
Genetic Techniques120054280.050 Why?
Kaplan-Meier Estimate3201965440.050 Why?
Registries5201884690.050 Why?
Artifacts1201018980.050 Why?
Medical Records2200614070.050 Why?
Ultrasonography1201459610.050 Why?
Genetic Predisposition to Disease32018177900.050 Why?
Sialoglycoproteins120023150.050 Why?
Pregnancy Complications1201429420.040 Why?
Intraoperative Complications1200711860.040 Why?
Recurrence1201384820.040 Why?
Predictive Value of Tests52020152890.040 Why?
Colposcopy120211500.040 Why?
Follow-Up Studies42018392610.040 Why?
Chorionic Gonadotropin, beta Subunit, Human22010810.040 Why?
Adnexa Uteri12019400.040 Why?
Germ Cells120236350.040 Why?
Neoplasms, Second Primary1200710560.040 Why?
Patient Readmission1201333230.040 Why?
Online Systems120191810.040 Why?
Omentum120191690.040 Why?
Estrogen Replacement Therapy2199512060.040 Why?
Diagnosis, Differential52018129650.040 Why?
Endometrium120204030.040 Why?
Genital Diseases, Female119991910.040 Why?
Estradiol2199519320.040 Why?
Pregnancy Outcome1200829070.040 Why?
Treatment Outcome42019650170.040 Why?
Diagnostic Tests, Routine120037860.040 Why?
Enzyme-Linked Immunosorbent Assay2202138040.040 Why?
Colorectal Neoplasms1201768530.040 Why?
Blood Loss, Surgical120216560.030 Why?
Sensitivity and Specificity42021146600.030 Why?
Organ Culture Techniques120187960.030 Why?
Mutation42018299320.030 Why?
Gene Expression Profiling2201694110.030 Why?
Brain Neoplasms1201789860.030 Why?
Carboplatin120187880.030 Why?
Drug Resistance, Neoplasm1201052530.030 Why?
Referral and Consultation2202135980.030 Why?
Microtubule-Associated Proteins1202010770.030 Why?
Length of Stay2202364790.030 Why?
Lymphocytes, Tumor-Infiltrating1202010880.030 Why?
Massachusetts3201888030.030 Why?
HeLa Cells1202131050.030 Why?
Deoxycytidine120188730.030 Why?
Estrone119952320.030 Why?
Triage120219870.030 Why?
Polysaccharides1202010160.030 Why?
Reverse Transcriptase Polymerase Chain Reaction2201645730.030 Why?
Organs at Risk120153580.030 Why?
Observer Variation1201926010.030 Why?
Prolactin119956210.030 Why?
Pyrazines1201811990.030 Why?
Apoptosis2202095010.030 Why?
Xenograft Model Antitumor Assays1202035840.030 Why?
Patient Positioning120153270.030 Why?
Appendicitis119996740.020 Why?
Fluorodeoxyglucose F181202020070.020 Why?
Adolescent52020878100.020 Why?
Obesity12014129220.020 Why?
Fluorescent Antibody Technique1201624710.020 Why?
DNA Replication1201814120.020 Why?
Killer Cells, Natural1202022030.020 Why?
Hyperglycemia1202013800.020 Why?
Motivation1202119930.020 Why?
Radiopharmaceuticals1202026340.020 Why?
Cancer Care Facilities120134240.020 Why?
Organoplatinum Compounds120124100.020 Why?
Dactinomycin120103040.020 Why?
Gravitation12009820.020 Why?
Etoposide120106300.020 Why?
Risk2201496310.020 Why?
Microscopy, Fluorescence1201626510.020 Why?
Taxoids120126690.020 Why?
Ethanol1199513230.020 Why?
Biopsy1202067710.020 Why?
Combined Modality Therapy2201485520.020 Why?
Cell Culture Techniques1201616640.020 Why?
Pyrazoles1201819990.020 Why?
Magnetic Resonance Imaging12015362900.020 Why?
Pilot Projects1202185550.020 Why?
Gene Regulatory Networks1201617410.020 Why?
Radiotherapy, Intensity-Modulated120138010.020 Why?
CD8-Positive T-Lymphocytes1202045500.020 Why?
Contraceptives, Oral120095540.020 Why?
Neoplasm, Residual1201210070.020 Why?
Menopause1199516400.020 Why?
Risk Assessment32020241230.020 Why?
Radiotherapy Planning, Computer-Assisted1201516600.020 Why?
Tomography, X-Ray Computed22020205090.020 Why?
Parity120099250.020 Why?
Curettage12005730.020 Why?
Postmenopause1199525090.020 Why?
Consensus1201531130.020 Why?
RNA, Messenger22016127660.020 Why?
Blood Glucose1202063810.020 Why?
Insulin1202065970.020 Why?
Alcohol Drinking2199540130.020 Why?
Organ Size1201022540.020 Why?
Genes, p53120077130.010 Why?
Family Health1200912570.010 Why?
Cyclophosphamide1201022210.010 Why?
Radiography1201569650.010 Why?
Body Mass Index22014129140.010 Why?
Decision Trees120065060.010 Why?
Randomized Controlled Trials as Topic12021103440.010 Why?
DNA Methylation1201743730.010 Why?
Neoplasm Metastasis1201349020.010 Why?
Administration, Cutaneous219957130.010 Why?
Apoptosis Regulatory Proteins1200711350.010 Why?
Survival Analysis12014101820.010 Why?
Age Distribution1200728930.010 Why?
Risk Reduction Behavior1200711090.010 Why?
Phenotype12018165460.010 Why?
Reproducibility of Results22014200800.010 Why?
Practice Guidelines as Topic1201874750.010 Why?
Osteopontin120023020.010 Why?
Cluster Analysis1200626980.010 Why?
Ultrasonography, Prenatal1200717450.010 Why?
Cross-Over Studies2199520610.010 Why?
Oligonucleotide Array Sequence Analysis1200637750.010 Why?
Clinical Trials as Topic1201380560.010 Why?
Positron-Emission Tomography1201364650.010 Why?
Cell Differentiation12014114810.010 Why?
Patient Compliance1200426880.010 Why?
Mice12020812080.010 Why?
Young Adult12020587410.010 Why?
Age Factors12009184160.010 Why?
Case-Control Studies12009220530.010 Why?
Random Allocation1199523940.010 Why?
Gene Expression1200275880.010 Why?
Animals120201679630.000 Why?
Acute Disease1199972690.000 Why?
Male120053597440.000 Why?
Analysis of Variance1199562380.000 Why?
Double-Blind Method11995124270.000 Why?
United States12004724610.000 Why?
Child11999798060.000 Why?
Feltmate's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (277)
Explore
_
Co-Authors (77)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.